1. Harm reduction progress is extremely limited. The tobacco industry is not phasing out cigarettes or transitioning smokers to reduced-risk alternatives quickly enough.

2. A small group of companies have made public commitments to harm reduction, but none have shifted their focus enough to ensure the accelerated decline of cigarettes and other high-risk products.

3. The majority of companies have not made any commitment to harm reduction and/or continue to set targets to increase sales.

4. The highest-ranked companies in the index are mostly publicly traded multinationals, while private and state owned companies lag behind.

5. Tobacco companies are focusing most of their reduced-risk product efforts on higher-income countries, while high-risk product sales in lower-income countries continue to grow.

6. Better disclosure and greater overall transparency are needed.

Key findings by Category

To search, type what you're looking for and results will appear automatically